Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Liquidia Corporation Closes Up 25% at $53.13 as YUTREPIA Delivers Third Straight Profitable Quarter on $130M Sales

Liquidia Corporation (Nasdaq: LQDA) delivered one of the most emphatic commercial readouts in the pulmonary hypertension space on Tuesday, sending its shares 25 per cent higher to close at $53.13 as investors digested a first-quarter performance that left little room for equivocation. YUTREPIA, the …

Nitish Kishor | 12 May 2026

Actuate Therapeutics Closes Down 10% at $2.98 Despite FDA Clearing IND for Oral Elraglusib in Solid Tumours

Actuate Therapeutics (Nasdaq: ACTU) closed 10 per cent lower at $2.98 on Tuesday, in what may rank as one of the more counterintuitive market reactions of the session. The company had just announced that the US Food and Drug Administration had cleared its Investigational …

Nitish Kishor | 12 May 2026

Aditxt Closes Down 8% at $0.11 as Nasdaq Delisting Letter Leaves Company Without a Grace Period

Aditxt, Inc. (NASDAQ: ADTX) closed 8 per cent lower at $0.11 on Tuesday as shareholders absorbed the implications of a Nasdaq Staff Determination letter that brought the company to the edge of a potentially terminal regulatory cliff. The disclosure confirmed what the share price …

Nitish Kishor | 12 May 2026

Ensysce Biosciences Closes Up 9% at $0.38 as CEO Showcases Abuse-Deterrent Opioid Platforms at European Summit

Shares in Ensysce Biosciences (Nasdaq: ENSC) closed 9 per cent higher at $0.38 on Tuesday, as the company placed itself at the centre of one of the most consequential debates in contemporary pharmacology: how to engineer effective pain relief without handing patients or recreational …

Nitish Kishor | 12 May 2026

aTyr Pharma Falls 9% to $0.87 in After-Hours Trading as Revised Phase 3 Strategy Resets Efzofitimod Timeline

aTyr Pharma (Nasdaq: ATYR) slipped 9 per cent to $0.87 in after-hours trading on Tuesday after the clinical-stage biotherapeutics company disclosed a revised Phase 3 strategy for efzofitimod in pulmonary sarcoidosis — a revision prompted by feedback from the US Food and Drug Administration …

Nitish Kishor | 12 May 2026

Geopolitics Broke the Oil Era. Renewables Are Filling the Void.

Energy transitions do not follow clean timelines. They are accelerated by crises, complicated byEconomics, and shaped as much by geopolitical necessity as by technological progress. The Iran conflict, which erased an estimated several million barrels per day of OPEC production in recent months, is …

Nitish Kishor | 12 May 2026

Alaska's Oil Revival: Why the World's Biggest Drillers Are Heading Back North

For nearly a decade, Alaska was written off. Shell (NYSE:SHEL) walked away in 2015 after losing $7bn on a failed offshore campaign. Exxon (NYSE:XOM) directed its exploration capital toward Guyana, where a major discovery in 2015 reshaped its reserve outlook. The North Slope, once …

Nitish Kishor | 12 May 2026

Beyond Tariffs: The Trump-Xi Summit's Quiet Currency Power Struggle

When President Trump and China's President Xi Jinping meet in Beijing this week, the formal agenda will be crowded. Tariffs, Taiwan, and sanctions will command the room. But running beneath every exchange is a contest that receives less attention and carries longer-term consequences: the …

Nitish Kishor | 12 May 2026

Iran Oil Shock Drives Hedge Funds Into Biofuel Commodities

When oil crosses USD 100 per barrel andSupplyroutes through the Strait of Hormuz face sustained disruption, the ripple effects do not stop at the energy complex. They travel into fertiliser markets, food supply chains, and increasingly, into theInvestmentstrategies of globalHedge Funds. The Iran conflict …

Nitish Kishor | 12 May 2026

Treasury yields climb as oil tops USD 100 and inflation data looms

U.S. Treasury yields pushed higher on Tuesday across the entire curve. The benchmark 10-year note added one basis point to 4.43%, the 30-year breached 5%, and the rate-sensitive 2-year climbed more than two basis points to 3.97%. Taken individually, none of these moves is …

Nitish Kishor | 12 May 2026
Support

Hi! How can we help you today?

Loading…